DRKS00006862已完成不适用
Treatment with new oral anticoagulants in primary care practices
niversitätsklinikum Bonn0 个研究点目标入组 353 人开始时间: 2015年3月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 353
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •GP patients who have been prescribed in the past two years one of the drugs of Pradaxa, Xarelto and Eliquis
排除标准
- •Duration of warfarin-taking before changing to the new oral anticoagulants <6 months
研究者
相似试验
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
进行中（未招募）
1 期
Direct oral Anticoagulants for Prevention of lEft ventRIcular Thrombus after anterior acute myocardial InFarctioeft ventricular (LV) thrombus after acute myocardial infarction (AMI)EUCTR2021-001534-19-FRAP-HP/DRCI560
招募中
不适用
The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)atrial fibrillationJPRN-UMIN000030673Tokyo Medical and Dental University1,000
招募中
不适用
Multi-effects of novel oral anticoagurants in nonvalvular atrial fibrillation studyJPRN-UMIN000010494Tokushima University hospital40
已完成
2 期
Oral blood thinners versus injectable blood thinners in preventing clotting disorders associated with COVID 19 infectioCTRI/2021/05/033871Dhiraj Kumar230